Shemesh Shay Insider Trading Activity

Average Profitability
28.02%
Insider Buys Quantity
13
Insider Buys Sum
$69,688.72
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Shemesh Shay

Biography of Shemesh Shay

No biography is available at this moment.

2024-05-10PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
1,113
0.006%
$6.32$7,034+3.59%
2023-03-21PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
420
0.0028%
$11.99$5,036+1.33%
2023-03-15PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
670
0.0044%
$10.71$7,176+14.37%
2022-12-21PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
500
0.0041%
$7.65$3,825+74.83%
2022-11-17PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
150
0.0012%
$7.20$1,080+78.47%
2022-11-16PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
150
0.0012%
$7.10$1,065+80.99%
2022-09-02PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
404
0.0029%
$8.31$3,357+37.88%
2022-08-31PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
1,530
0.0108%
$8.07$12,347+39.81%
2022-05-20PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
300
0.0025%
$16.54$4,962-40.84%
2022-05-16PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
142
0.0011%
$19.55$2,776-51.5%
2022-05-12PurchaseNuvectis Pharma, Inc.
NVCT
Chief Dev. & Ops. Officer
58
0.0004%
$16.61$963-48.4%
2022-02-07PurchaseNuvectis Pharma, Inc.
NVCT
Chief Development Officer
1,692
0.0081%
$3.47$5,871+1.64%
2022-02-04PurchaseNuvectis Pharma, Inc.
NVCT
Chief Development Officer
4,200
0.0477%
$3.38$14,196+147.69%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.